PAIN
Volume 148, Issue 1 , Pages 26-35 , January 2010

Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids

  • Alejandro Telleria-Diaz

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • These authors contributed equally to this work.
    • ,
  • Martin Schmidt

      Affiliations

    • Department of Biochemistry, University Hospital of Jena, Nonnenplan 2, D-07740 Jena, Germany
    • These authors contributed equally to this work.
    • ,
  • Stefan Kreusch

      Affiliations

    • Department of Biochemistry, University Hospital of Jena, Nonnenplan 2, D-07740 Jena, Germany
    • ,
  • Anne-Kathrin Neubert

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • ,
  • Florian Schache

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • ,
  • Enrique Vazquez

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • On leave from the Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas, Venezuela.
    • ,
  • Horacio Vanegas

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • On leave from the Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas, Venezuela.
    • ,
  • Hans-Georg Schaible

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • ,
  • Andrea Ebersberger

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 3641 938814; fax: +49 3641 938812.

Received 16 February 2009 ,Revised 12 August 2009 ,Accepted 17 August 2009.

References 

  1. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci. 2007;10:870–879
  2. Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU. PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci. 2002;5:34–40
  3. Baba H, Kohno T, Moore KA, Woolf CJ. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci. 2001;21:1750–1756
  4. Bär K-J, Natura G, Telleria-Diaz A, Teschner P, Vogel R, Vasquez E, et al. Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1–EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint. J Neurosci. 2004;24:642–651
  5. Bazan NG, Flower RJ. Lipid signals in pain control. Nature. 2002;420:135–138
  6. Binzen U, Greffrath W, Hennessy S, Bausen M, Saaler-Reinhardt S, Treede RD. Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons. Neuroscience. 2002;142:527–539
  7. Boettger MK, Hensellek S, Richter F, Gajda M, Stöckigt R, Segond von Banchet G, et al. Antinociceptive effects of TNF-α neutralization in a rat model of antigen-induced arthritis. Arthritis Rheum. 2008;58:2368–2378
  8. Boyce S, Chan CC, Gordon R, Li CS, Rodger IW, Webb JK, et al. L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacol. 1994;33:1609–1611
  9. Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with a ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther. 1994;274:1531–1537
  10. Choong KC, Su X, Urban MO. Effect of CB55,940 on mechanosensory spinal neurons following chronic inflammation. Neurosci Lett. 2007;414:105–109
  11. Dembo G, Park SB, Kharasch ED. Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology. 2005;102:409–415
  12. Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL, et al. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol. 2005;569:751–760
  13. Farquhar-Smith WP, Egertová M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR. Cannabinoid CB(1) receptor expression in at spinal cord. Mol Cell Neurosci. 2000;15:510–521
  14. Ferreira SH. Peripheral analgesic sites of action of anti-inflammatory drugs. Int J Clin Pract. 2002;Suppl. 128:2–10
  15. Ghilardi JR, Svensson CI, Rogers SD, Yaksh TL, Mantyh PW. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J Neurosci. 2004;24:2727–2732
  16. Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron. 2008;57:746–759
  17. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in the rat brain. Brain Res. 2006;1071:10–23
  18. Gühring H, Hanza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, et al. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol. 2002;454:153–163
  19. Guilbaud G, Iggo A. The effect of acetylsalicylate on joint mechanoreceptors in rats with polyarthritis. Exp Brain Res. 1985;61:164–168
  20. Heppelmann B, Pfeffer A, Schaible H-G, Schmidt RF. Effects of acetylsalicylic acid (ASA) and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain. 1986;26:337–351
  21. Hohmann AG, Tsou K, Walker JM. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci Lett. 1998;257:119–122
  22. Holt S, Fowler CJ. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra – but not intracellular pH. Naunyn Schmiedebergs Arch Pharmacol. 2003;36737–36744
  23. Hsueh S-F, Lu C-Y, Chao C-S, Tan P-H, Huang Y-W, Hsieh S-W, et al. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation. Mol Brain Res. 2004;125:113–119
  24. Ibuki T, Matsumura K, Yamazaki Y, Nozaki T, Tanaka Y, Kobayashi S. Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J Neurochem. 2003;86:318–328
  25. Jennings EA, Vaughan CW, Roberts LA, Christie MJ. The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J Physiol. 2003;548:121–129
  26. Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152:624–632
  27. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF. Cyclooxygenases and the central nervous system. Prostaglandins. 1997;54:601–624
  28. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA. 1996;93:2317–2321
  29. Kim J, Alger BE. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci. 2004;7:697–698
  30. Kozak KR, Marnett LJ. Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids. 2002;66:211–220
  31. Kozak KR, Prusakiewicz JJ, Marnett LJ. Oxidative metabolism of endocannabinoids by COX-2. Curr Pharm Des. 2004;10:659–667
  32. Lee IO, Seo Y. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or non-selective inhibitors on pain behavior and spinal Fos-like immunoreactivity. Anesth Analg. 2008;106:972–977
  33. Liang X, Wu L, Wang Q, Hand T, Bilak M, McCullough L, et al. Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci. 2007;33:94–99
  34. Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. J Pharmacol Exp Ther. 1991;258:517–523
  35. Ma W, Du W, Eisenach JC. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 2002;937:94–99
  36. Maihöfner C, Tegeder I, Euchenhofer C, deWitt D, Brune K, Bang R, et al. Localization and regulation of cyclooxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience. 2000;101:1093–1108
  37. Minghetti L. Role of COX-2 in inflammatory and degenerative brain diseases. Subcell Biochem. 2007;42:127–141
  38. Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006;11:680–684
  39. Neugebauer V, Lücke T, Schaible H-G. N-Methyl-d-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat’s knee joint. J Neurophysiol. 1993;70:1365–1377
  40. Neugebauer V, Lücke T, Schaible H-G. Requirement of metabotropic glutamate receptors for the generation of inflammation-evoked hyperexcitability in rat spinal cord neurons. Eur J Neurosci. 1994;6:1179–1186
  41. Neugebauer V, Rümenapp P, Schaible H-G. Calcitonin gene-related peptide is involved in the generation and maintenance of hyperexcitability of dorsal horn neurons observed during development of acute inflammation in rat’s knee joint. Neuroscience. 1996;71:1095–1109
  42. Neugebauer V, Weiretter F, Schaible H-G. The involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat’s knee joint. J Neurophysiol. 1995;73:1574–1583
  43. Oka S, Arai S, Waku K, Tokumura A, Sugiura T. Depolarization-induced rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain synaptosomes. J Biochem (Tokyo). 2007;141:687–697
  44. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci. 2006;1074:514–536
  45. Richardson JD, Aanonsen L, Hargreaves KM. Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol. 1998;345:145–153
  46. Richardson JD, Aanonsen L, Hargreaves KM. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J Neurosci. 1998;18:451–457
  47. Richardson D, Ortori CA, Chapman V, Kendall DA, Barett DA. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography–tandem electrospray ionization mass spectrometry. Anal Biochem. 2007;360:216–226
  48. Salio C, Doly S, Fischer J, Franzoni MF, Conrath M. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci Lett. 2002;329:13–16
  49. Salio C, Fischer J, Franzoni MF, Mackie K, Kaneko T, Conrath M. CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in rat dorsal horn. Neuroreport. 2001;12:3689–3692
  50. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al. Interleukin-1β-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471–475
  51. Segond von Banchet G, Petrow PK, Bräuer R, Schaible H-G. Monoarticular antigen-induced arthritis leads to pronounced bilateral upregulation of the expression of neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurones of rats. Arthritis Res. 2000;2:424–427
  52. Slanina KA, Schweitzer P. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology. 2005;49:653–659
  53. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA. 1998;95:13313–13318
  54. Svensson CI, Yaksh TL. The spinal phospholipase-prostanoid cascade in nociceptive processing. Annu Rev Toxicol. 2002;42:553–583
  55. Tegeder I, Niederberger E, Vetter G, Bräutigam L, Geisslinger G. Effects of selective COX-1 and COX-2 inhibition on formalin-evoked nociceptive behavior and prostaglandin E2 release in the spinal cord. J Biochem. 2001;79:777–786
  56. Van Der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem. 2004;271:1827–1834
  57. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 1971;231:232–235
  58. Vanegas H, Schaible H-G. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol. 2001;64:327–363
  59. Vasquez E, Bär K-J, Ebersberger A, Klein B, Vanegas H, Schaible H-G. Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability. J Neurosci. 2001;21:9001–9008
  60. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD. Prostanoids synthesized by cyclooxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol. 1997;122:1593–1604
  61. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–1768
  62. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 1993;11:371–386
  63. Yamamoto T, Nozaki-Taguchi N. Analysis of the effects of cyclooxygenase COX-1 and COX-2 spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS398, a COX-2 selective inhibitor. Brain Res. 1996;739:104–110
  64. Yamamoto T, Nozaki-Taguchi N. Analysis of the roles of cyclooxygenase COX-1 and COX-2 in spinal nociceptive transmission. Progr Pain Res Manag. 1997;8:303–312
  65. Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O’Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci. 2003;17:2750–2754
  66. Zhu X, Conklin DR, Eisenach JC. Preoperative inhibition of cyclooxygenase-1 in the spinal cord reduces postoperative pain. Anesth Analg. 2005;100:1390–1393

PII: S0304-3959(09)00460-6

doi: 10.1016/j.pain.2009.08.013

PAIN
Volume 148, Issue 1 , Pages 26-35 , January 2010

Article Tools

* Image Usage & Resolution